ABUS vs EBAY · P/E 5.4, rev $6.2M vs P/E 25, rev $10.28B
Arbutus Biopharma Corp (ABUS) versus eBay Inc (EBAY) — a side-by-side from cached financials, not a winner call.
Arbutus Biopharma Corp (ABUS) is a biotechnology company listed on NASDAQ.
eBay Inc (EBAY) is a internet retail company listed on NASDAQ.
Latest reported ABUS revenue for 2024-12-31 was $6.2M. Net income was -$69.9M. Revenue was down 66.0% from 2023-12-31 to 2024-12-31. ABUS currently screens at market cap $883.0M and trailing P/E 5.4.
Latest reported EBAY revenue for 2024-12-31 was $10.28B. Net income was $1.98B. Revenue was up 1.7% from 2023-12-31 to 2024-12-31. EBAY currently screens at market cap $47.90B and trailing P/E 24.9.
ABUS currently screens at market cap $883.0M and trailing P/E 5.4. EBAY currently screens at market cap $47.90B and trailing P/E 24.9.
Not investment advice. Open the ABUS and EBAY stock pages for the full models.
Not investment advice.